000 01439 a2200397 4500
005 20250511220712.0
264 0 _c19910708
008 199107s 0 0 eng d
022 _a0009-7322
024 7 _a10.1161/01.cir.83.6.2038
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrostell, C
245 0 0 _aInhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.
_h[electronic resource]
260 _bCirculation
_cJun 1991
300 _a2038-47 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Inhalation
650 0 4 _aAnimals
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Tolerance
650 0 4 _aHypoxia
_xphysiopathology
650 0 4 _aInfusions, Intravenous
650 0 4 _aNitric Oxide
_xadministration & dosage
650 0 4 _aProstaglandin Endoperoxides, Synthetic
_xpharmacology
650 0 4 _aPulmonary Circulation
_xdrug effects
650 0 4 _aSheep
650 0 4 _aTime Factors
650 0 4 _aVasoconstriction
_xdrug effects
650 0 4 _aVasodilator Agents
_xpharmacology
700 1 _aFratacci, M D
700 1 _aWain, J C
700 1 _aJones, R
700 1 _aZapol, W M
773 0 _tCirculation
_gvol. 83
_gno. 6
_gp. 2038-47
856 4 0 _uhttps://doi.org/10.1161/01.cir.83.6.2038
_zAvailable from publisher's website
999 _c2046237
_d2046237